Tekla Capital Management LLC Rocket Pharmaceuticals, Inc. Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$20.5 - $28.59 $5.93 Million - $8.26 Million
-289,029 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$13.32 - $22.61 $1.09 Million - $1.84 Million
81,474 Added 39.25%
289,029 $6.05 Million
Q3 2019

Nov 13, 2019
BUY
$10.85 - $14.78 $2.25 Million - $3.07 Million
207,555 New
207,555 $2.42 Million

Others Institutions Holding RCKT

# of Institutions
194
Shares Held
91.9M
Call Options Held
222K
Put Options Held
111K
View Full List

About ROCKET PHARMACEUTICALS, INC.

RCKT Quotes by TradingView
  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $1.4B
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email